Control Bionics Ltd. · ASX:CBL

Stephen Rix received 1,044,087 Control Bionics Ltd. shares as an award (Appendix 3Y, ASX)

Traded Oct 19, 2026 · Filed Oct 19, 2026

On Oct 19, 2026, Stephen Rix (Director) received 1,044,087 Control Bionics Ltd. shares as an award at AUD 0.06 for AUD 62,356. Filed Oct 19, 2026 (Appendix 3Y, ASX).

Awarded
1,044,087 shares
Price
AUD 0.06
Value
AUD 62,356
Role
Director

The filing in full

Appendix 3Y

*Rule 3.19A.2*

Change of Director’s Interest Notice

*Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.*

Introduced 30/09/01 Amended 01/01/11

Name of entityCONTROL BIONICS LIMITED
ABN45 115 465 462

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.

Name of DirectorStephen Rix
Date of last notice1 September 2026

Part 1 - Change of director’s relevant interests in securities

*In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust*

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should
be disclosed in this part.

Direct or indirect interestDirect and Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.Director and shareholder Windward Capital Pty Limited
Date of change19 October 2026
No. of securities held prior to change1. 8,959,913 ordinary shares 2. 300,001 options
ClassOrdinary shares
Number acquired1,044,087
Number disposedNil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation$62,356
No. of securities held after change1. 10,004,000 2. 300,001
  • See chapter 19 for defined terms.

---

Nature of changeExample: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-backShares issued in lieu of directors fees – approved at 2026 AGM

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should
be disclosed in this part.

Detail of contractNA
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change

+ Part 3 – Closed period

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?No
If so, was prior written clearance provided to allow the trade to proceed during this period?
If prior written clearance was provided, on what date was this provided?
  • See chapter 19 for defined terms.
DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 19, 2026Ordinary sharesAward1,044,087AUD 0.06

Source

Download PDF · View original at ASX

Related